Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001017491-18-000004
Filing Date
2018-01-03
Accepted
2018-01-03 19:45:06
Documents
1
Period of Report
2018-01-01

Document Format Files

Seq Description Document Type Size
1 FORM 4 wf-form4_151502669108006.html 4  
1 FORM 4 wf-form4_151502669108006.xml 4 5664
  Complete submission text file 0001017491-18-000004.txt   7187
Mailing Address 11975 EL CAMINO REAL, SUITE 300 SAN DIEGO, CA 92130
Business Address 11975 EL CAMINO REAL, SUITE 300 SAN DIEGO, CA 92130 (858) 222-8041
APRICUS BIOSCIENCES, INC. (Issuer) CIK: 0001017491 (see all company filings)

EIN.: 870449967 | State of Incorp.: NV | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O SOMAXON PHARMACEUTICALS, INC. 10935 VISTA SORRENTO PARKWAY, SUITE 250 SAN DIEGO CA 92130
Business Address
Pascoe Richard W (Reporting) CIK: 0001343266 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-22245 | Film No.: 18507962